These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 29642210)

  • 1. VEGF levels in plasma in relation to metabolic control, inflammation, and microvascular complications in type-2 diabetes: A cohort study.
    Zhang Q; Fang W; Ma L; Wang ZD; Yang YM; Lu YQ
    Medicine (Baltimore); 2018 Apr; 97(15):e0415. PubMed ID: 29642210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum and Plasma Levels of Vascular Endothelial Growth Factors in Relation to Quality of Glucose Control, Biomarkers of Inflammation, and Diabetic Nephropathy.
    Hanefeld M; Appelt D; Engelmann K; Sandner D; Bornstein SR; Ganz X; Henkel E; Haase R; Birkenfeld AL
    Horm Metab Res; 2016 Aug; 48(8):529-34. PubMed ID: 27388431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor (VEGF) in children, adolescents and young adults with Type 1 diabetes mellitus: relation to glycaemic control and microvascular complications.
    Chiarelli F; Spagnoli A; Basciani F; Tumini S; Mezzetti A; Cipollone F; Cuccurullo F; Morgese G; Verrotti A
    Diabet Med; 2000 Sep; 17(9):650-6. PubMed ID: 11051284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of vascular endothelial growth factor plasma levels and glycemic control in patients with diabetic retinopathy.
    Zehetner C; Kirchmair R; Kralinger M; Kieselbach G
    Acta Ophthalmol; 2013 Sep; 91(6):e470-3. PubMed ID: 23452413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VEGF levels in plasma in relation to platelet activation, glycemic control, and microvascular complications in type 1 diabetes.
    Schlingemann RO; Van Noorden CJ; Diekman MJ; Tiller A; Meijers JC; Koolwijk P; Wiersinga WM
    Diabetes Care; 2013 Jun; 36(6):1629-34. PubMed ID: 23321217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations between Adiponectin Gene Variability, Proinflammatory and Angiogenetic Markers: Implications for Microvascular Disease Development in Type 2 Diabetes Mellitus?
    Kollia C; Antonopoulos AS; Siasos G; Konsola T; Oikonomou E; Gouliopoulos N; Tsigkou V; Papapanagiotou A; Kassi E; Tentolouris N; Katsiki N; Vavuranakis M; Papavassiliou AG; Tousoulis D
    Curr Vasc Pharmacol; 2019; 17(2):204-208. PubMed ID: 29308741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma vascular endothelial growth factor, angiopoietin-1, and angiopoietin-2 in diabetes: implications for cardiovascular risk and effects of multifactorial intervention.
    Lim HS; Blann AD; Chong AY; Freestone B; Lip GY
    Diabetes Care; 2004 Dec; 27(12):2918-24. PubMed ID: 15562207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.
    Cardoso CRL; Leite NC; Moram CBM; Salles GF
    Cardiovasc Diabetol; 2018 Feb; 17(1):33. PubMed ID: 29477146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association of serum vascular endothelial growth factor and ferritin in diabetic microvascular disease.
    Guo L; Jiang F; Tang YT; Si MY; Jiao XY
    Diabetes Technol Ther; 2014 Apr; 16(4):224-34. PubMed ID: 24279470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of osteoprotegerin and vascular endothelial growth factor in normoalbuminuric Type 1 diabetic and control subjects.
    Esteghamati A; Arefzadeh A; Zandieh A; Salehi Sadaghiani M; Noshad S; Nakhjavani M
    J Endocrinol Invest; 2013; 36(7):474-7. PubMed ID: 23877020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between glycemic control and plasma vascular endothelial growth factor and endothelin-1 concentration in diabetic patients.
    Kakizawa H; Itoh M; Itoh Y; Imamura S; Ishiwata Y; Matsumoto T; Yamamoto K; Kato T; Ono Y; Nagata M; Hayakawa N; Suzuki A; Goto Y; Oda N
    Metabolism; 2004 May; 53(5):550-5. PubMed ID: 15131756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative predictive ability of visit-to-visit HbA1c variability measures for microvascular disease risk in type 2 diabetes.
    Yang CY; Su PF; Hung JY; Ou HT; Kuo S
    Cardiovasc Diabetol; 2020 Jul; 19(1):105. PubMed ID: 32631323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of correlation between the optimal glycaemic control and coronary micro vascular dysfunction in patients with diabetes mellitus: a cross sectional study.
    Valenzuela-Garcia LF; Matsuzawa Y; Sara JD; Kwon TG; Lennon RJ; Lerman LO; Ruiz-Salmeron RJ; Lerman A
    Cardiovasc Diabetol; 2015 Aug; 14():106. PubMed ID: 26268857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of glycemic control on aortic stiffness, left ventricular mass and diastolic longitudinal function in type 2 diabetes mellitus.
    Kozakova M; Morizzo C; Fraser AG; Palombo C
    Cardiovasc Diabetol; 2017 Jun; 16(1):78. PubMed ID: 28623932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Increased Circulating Plasma Levels of Vascular Endothelial Growth Factor in Patients with Type 1 Diabetes Do Not Correlate to Metabolic Control.
    Singh K; Sandler S; Espes D
    J Diabetes Res; 2017; 2017():6192896. PubMed ID: 28421206
    [No Abstract]   [Full Text] [Related]  

  • 16. The relation between plasma endothelin-1 levels and metabolic control, risk factors, treatment modalities, and diabetic microangiopathy in patients with Type 2 diabetes mellitus.
    Ak G; Buyukberber S; Sevinc A; Turk HM; Ates M; Sari R; Savli H; Cigli A
    J Diabetes Complications; 2001; 15(3):150-7. PubMed ID: 11358684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum angiopoietin-2 is associated with angiopathy in type 2 diabetes mellitus.
    Li L; Qian L; Yu ZQ
    J Diabetes Complications; 2015; 29(4):568-71. PubMed ID: 25754501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Features and Microvascular Complications Risk Factors of Early-onset Type 2 Diabetes Mellitus.
    Huang JX; Liao YF; Li YM
    Curr Med Sci; 2019 Oct; 39(5):754-758. PubMed ID: 31612393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum CA 19-9 Level is Correlated to the Clinical Characteristics and Chronic Complications of Patients Newly Diagnosed with Type 2 Diabetes Mellitus.
    Cui L; Lv N; Li B; Tao J; Zheng X; Yan Y; Liu C
    Exp Clin Endocrinol Diabetes; 2021 Aug; 129(8):581-586. PubMed ID: 31461764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycemic Variability and Vascular Complications in Patients with Type 2 Diabetes Mellitus.
    Caprnda M; Mesarosova D; Ortega PF; Krahulec B; Egom E; Rodrigo L; Kruzliak P; Mozos I; Gaspar L
    Folia Med (Plovdiv); 2017 Sep; 59(3):270-278. PubMed ID: 28976897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.